|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
1999-5-6
|
|
pubmed:abstractText |
Although long-term prostacyclin (PGI2) has been shown to improve hemodynamics, quality of life, and survival in patients with primary pulmonary hypertension, its use in patients with pulmonary hypertension (PHT) and associated congenital heart defects (CHD) has not been evaluated.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
13
|
|
pubmed:volume |
99
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1858-65
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10199883-Adult,
pubmed-meshheading:10199883-Antihypertensive Agents,
pubmed-meshheading:10199883-Child,
pubmed-meshheading:10199883-Child, Preschool,
pubmed-meshheading:10199883-Epoprostenol,
pubmed-meshheading:10199883-Female,
pubmed-meshheading:10199883-Heart Defects, Congenital,
pubmed-meshheading:10199883-Hemodynamics,
pubmed-meshheading:10199883-Humans,
pubmed-meshheading:10199883-Hypertension, Pulmonary,
pubmed-meshheading:10199883-Infant,
pubmed-meshheading:10199883-Male,
pubmed-meshheading:10199883-Physical Endurance,
pubmed-meshheading:10199883-Severity of Illness Index,
pubmed-meshheading:10199883-Time Factors,
pubmed-meshheading:10199883-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.
|
|
pubmed:affiliation |
Division of Pediatric Cardiology, Columbia Presbyterian Medical Center, New York, NY, USA. esb14@columbia.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|
